Source: Oxidative Medicine and Cellular Longevity. Unidade: FM
Subjects: TRANSPLANTE DE RIM, TESTES SOROLÓGICOS, FÁRMACOS IMUNOSSUPRESSORES, DIABETES MELLITUS (COMPLICAÇÕES)
ABNT
MARTINS, La Salete et al. Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments. Oxidative Medicine and Cellular Longevity, v. 2016, p. 11 , 2016Tradução . . Disponível em: https://doi.org/10.1155/2016/2189582. Acesso em: 30 set. 2024.APA
Martins, L. S., Oliveira, J. C., Vizcaíno, J. R., Fonseca, I., Gouveia, C., Silva, D., et al. (2016). Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments. Oxidative Medicine and Cellular Longevity, 2016, 11 . doi:10.1155/2016/2189582NLM
Martins LS, Oliveira JC, Vizcaíno JR, Fonseca I, Gouveia C, Silva D, Henriques AC, Noronha IL, Rodrigues A. Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments [Internet]. Oxidative Medicine and Cellular Longevity. 2016 ; 2016 11 .[citado 2024 set. 30 ] Available from: https://doi.org/10.1155/2016/2189582Vancouver
Martins LS, Oliveira JC, Vizcaíno JR, Fonseca I, Gouveia C, Silva D, Henriques AC, Noronha IL, Rodrigues A. Advanced Glycation End Products Evolution after Pancreas-Kidney Transplantation: Plasmatic and Cutaneous Assessments [Internet]. Oxidative Medicine and Cellular Longevity. 2016 ; 2016 11 .[citado 2024 set. 30 ] Available from: https://doi.org/10.1155/2016/2189582